VHL-Associated Renal Cell Carcinoma

Oncology

Prevalence

30.0 / 100K

0 drugs in development·0 companies·1 clinical trial

Frequently asked questions

How many clinical trials target VHL-Associated Renal Cell Carcinoma?

There are 1 clinical trial targeting VHL-Associated Renal Cell Carcinoma tracked by BioSniper.

What is the prevalence of VHL-Associated Renal Cell Carcinoma?

The estimated prevalence of VHL-Associated Renal Cell Carcinoma is approximately 30.0 per 100,000 population.

Deep-dive into VHL-Associated Renal Cell Carcinoma

Full trial data, competitive analysis, and AI-powered pipeline tracking.

Start Free Analysis
    VHL-Associated Renal Cell Carcinoma — Drugs in Development & Clinical Trials | BioSniper